<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001224091</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001088856</issuerCik>
      <issuerName>CORCEPT THERAPEUTICS INC</issuerName>
      <secFileNumber>000-50679</secFileNumber>
      <issuerAddress>
        <com:street1>149 COMMONWEALTH DRIVE</com:street1>
        <com:city>MENLO PARK</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94025</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650.688.8803</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MAHONEY DAVID L</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab Corporation</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>10000</noOfUnitsSold>
      <aggregateMarketValue>308700.00</aggregateMarketValue>
      <noOfUnitsOutstanding>102546606</noOfUnitsOutstanding>
      <approxSaleDate>08/14/2023</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/11/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Agios Pharmaceuticals</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>21297</amountOfSecuritiesAcquired>
      <paymentDate>05/11/2021</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/14/2023</noticeDate>
      <signature>David L Mahoney</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2728}]
144
0001224091
XXXXXXXX
LIVE
0001088856
CORCEPT THERAPEUTICS INC
000-50679
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
650.688.8803
MAHONEY DAVID L
Director
Common
Charles Schwab Corporation
3000 Schwab Way
Westlake
TX
76262
10000
308700.00
102546606
08/14/2023
Nasdaq
Common
05/11/2021
Stock Option Exercise
Agios Pharmaceuticals
N
21297
05/11/2021
Cash
Y
08/14/2023
David L Mahoney